Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Patient-Specific Vaccination With Conjugated Follicular Lymphoma-Derived Idiotype (FNHLId1) With Local GM-CSF in First Complete Remission

NCT00091676 is registered in ClinicalTrials.gov with Biovest International as lead sponsor.

NCT NCT00091676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00091676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Patient-Specific Vaccination With Conjugated Follicular Lymphoma-Derived Idiotype (FNHLId1) With Local GM-CSF in First Complete Remission
Lead sponsor
Biovest International
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2000
Completion date
December 31, 2012
Enrollment
629 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkins lymphoma